共 44 条
- [3] Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial [J]. LANCET ONCOLOGY, 2021, 22 (05) : 665 - 677
- [6] Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO
- [7] 2-P
- [8] The roles of mast cells in anticancer immunity [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (09) : 1511 - 1520